Common misconceptions

Common mistake
Wrong: The first step in diagnosing Cushing syndrome is measuring serum cortisol or ACTH.
Right: The first step is to confirm hypercortisolism using a screening test (24-hour urine free cortisol, late-night salivary cortisol, or 1 mg overnight dexamethasone suppression test) before localizing the source.
Jumping straight to ACTH measurement puts the cart before the horse — ACTH tells you where the cortisol is coming from, but you haven't yet confirmed there's actually excess cortisol. The first step is always to document hypercortisolism biochemically using a screening test (24-hour urine free cortisol, late-night salivary cortisol, or 1 mg overnight dex suppression test). Only after confirming elevated cortisol do you measure ACTH to separate ACTH-dependent from ACTH-independent causes.
Common mistake
Wrong: Ectopic ACTH-secreting tumors will suppress cortisol on high-dose dexamethasone suppression testing, like pituitary adenomas.
Right: Ectopic ACTH sources (e.g., small cell lung cancer) do not suppress on high-dose dexamethasone, whereas pituitary adenomas (Cushing disease) typically show >50% suppression.
Pituitary adenomas retain partial feedback sensitivity — they produce ACTH but still respond to supraphysiologic glucocorticoid levels, which is why high-dose dexamethasone suppresses cortisol by more than 50% in Cushing disease. Ectopic ACTH-secreting tumors (like small cell lung cancer) are autonomous and have no feedback receptors, so they don't suppress on high-dose dex at all. This difference is the key discriminator between pituitary and ectopic sources once you've confirmed ACTH-dependent Cushing.
Common mistake
Wrong: Hyperpigmentation in Cushing syndrome indicates primary adrenal disease.
Right: Hyperpigmentation occurs when ACTH (and its precursor POMC-derived peptides) is elevated, which happens in Cushing disease and ectopic ACTH syndrome, not in adrenal-source Cushing where ACTH is suppressed.
Hyperpigmentation is driven by ACTH and co-secreted POMC-derived peptides (including MSH) acting on melanocortin-1 receptors in the skin — it's a marker of high ACTH, not high cortisol. In adrenal-source Cushing, autonomous cortisol production suppresses ACTH to very low levels, so there's no pigmentation. Hyperpigmentation actually points toward Cushing disease or ectopic ACTH syndrome, where ACTH is elevated, not toward an adrenal cause.
Common mistake
Wrong: Exogenous glucocorticoid use (the most common cause of Cushing syndrome) will show elevated ACTH levels.
Right: Exogenous glucocorticoids suppress the HPA axis, resulting in low ACTH and low endogenous cortisol; this is the most common cause of Cushing syndrome overall.
Exogenous glucocorticoids mimic cortisol and exert negative feedback on the hypothalamus and pituitary, shutting down CRH and ACTH secretion. The result is low ACTH and low endogenous cortisol — the adrenal glands actually atrophy from disuse. This is the most common cause of Cushing syndrome overall, and its lab pattern (low ACTH, low endogenous cortisol, clinical hypercortisolism) is the opposite of what you'd see with an ACTH-secreting tumor.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Recognize the multisystem features of hypercortisolism — including central obesity, striae, proximal muscle weakness, hypertension, hyperglycemia, osteoporosis, and immune suppression — and know which findings are most specific.
  2. Apply the three-step diagnostic workup: first confirm hypercortisolism with a screening test (24-hour urine free cortisol, late-night salivary cortisol, or 1 mg overnight dexamethasone suppression test), then check ACTH to determine ACTH-dependent vs. independent, then localize the source with imaging or high-dose dexamethasone suppression testing.
  3. Distinguish ectopic ACTH syndrome from pituitary Cushing disease using clinical clues (rapid onset, severe hypokalemia, hyperpigmentation, underlying malignancy) and laboratory behavior (no suppression on high-dose dexamethasone in ectopic vs. >50% suppression in pituitary adenoma).
  4. Match each cause of Cushing syndrome to its directed management: transsphenoidal resection for pituitary adenoma, surgical resection for adrenal adenoma or ectopic tumor, and gradual glucocorticoid taper with HPA axis recovery monitoring for exogenous steroid-induced Cushing.

Can you avoid these mistakes?

A 45-year-old woman presents with central obesity, easy bruising, and new-onset hypertension. You suspect Cushing syndrome. What is the correct first diagnostic step, and why is ordering a serum ACTH at this point premature?
A patient with a known small cell lung carcinoma develops profound hypokalemia, hyperpigmentation, and markedly elevated 24-hour urine free cortisol. High-dose dexamethasone suppression testing shows no suppression. What is the diagnosis, and how does the dexamethasone result help you exclude a pituitary adenoma?
Two patients both have confirmed ACTH-dependent Cushing syndrome. Patient A has hyperpigmentation and a cortisol level that does not suppress on high-dose dex. Patient B has mild hyperpigmentation and cortisol that suppresses >50% on high-dose dex. What is the most likely diagnosis for each, and what is the appropriate surgical approach for each?
A 55-year-old man with rheumatoid arthritis has been on prednisone 20 mg/day for 2 years and now has a cushingoid appearance. You check his labs: what would you expect his ACTH and endogenous cortisol levels to show, and what is the danger if you abruptly stop his prednisone?

Related topics

See how your Anki deck covers this topic.

Upload your deck for a free audit →